Translating single-cell microfluidics from academic lab to global biotech impact – Dr. Carl Hansen

We’re honoured to welcome Dr Carl Hansen, CEO & Co-Founder of AbCellera, for a special research seminar hosted by the UBC School of Biomedical Engineering: “Translating single-cell microfluidics from academic lab to global biotech impact” 

Tuesday, June 10, 2025 | 11:00 AM – 12:00 PM PT | SBME Lecture Theatre B1009 + Zoom

Dr. Carl Hansen is the founding CEO of AbCellera. He is a scientist, inventor, teacher and entrepreneur whose work is represented in over 90 peer-reviewed manuscripts and abstracts, and more than 75 patent applications. Carl is the recipient of numerous awards, including EY Canada’s Entrepreneur of Year and the 2021 Bloom Burton Award, and was profiled in Forbes magazine. Under his leadership, AbCellera was a contractor for the Pandemic Preparedness Program of the Defense Advanced Research Program Agency (DARPA) and developed two therapeutic antibodies against COVID-19 that were administered to 2 million patients in the US.  Prior to AbCellera, Carl attained the rank of Full Professor at the University of British Columbia, jointly appointed in the Michael Smith Labs and the Department of Physics and Astronomy. Carl received his PhD in Applied Physics (specialty in biotechnology) from Caltech and obtained a BASc in Engineering Physics and Honors Mathematics from the University of British Columbia.